Fmoc-L-Thr(β-D-GlcNAc(Ac)3)-OH

Fmoc-L-Thr(β-D-GlcNAc(Ac)3)-OH is a highly specialized glycosylated amino acid derivative that plays a pivotal role in the synthesis of complex glycopeptides and glycoproteins. Featuring an N-acetylglucosamine (GlcNAc) moiety linked to threonine, this compound is protected with an Fmoc group on the amino terminus and acetyl groups on the sugar, making it compatible with standard Fmoc-based solid-phase peptide synthesis protocols. The unique structure of Fmoc-L-Thr(β-D-GlcNAc(Ac)3)-OH allows for the efficient incorporation of O-linked β-D-GlcNAc modifications into peptides, which are crucial for mimicking naturally occurring post-translational modifications found in eukaryotic proteins. The stability of the acetyl-protected GlcNAc during peptide assembly and the ease of deprotection further enhance its suitability for advanced synthetic and research applications. As a result, this glycosylated amino acid is widely adopted in academic and industrial laboratories focused on glycobiology, chemical biology, and synthetic peptide research.

Glycopeptide Synthesis: Fmoc-L-Thr(β-D-GlcNAc(Ac)3)-OH is extensively used for the synthesis of O-linked glycopeptides, enabling researchers to study the structural and functional consequences of site-specific glycosylation. By incorporating this building block into peptide chains during solid-phase synthesis, scientists can generate homogeneous glycopeptides that closely mimic natural glycoproteins. These synthetic glycopeptides are invaluable tools for exploring the role of O-GlcNAc modifications in protein folding, stability, and molecular recognition events. The ability to introduce a defined GlcNAc modification at specific threonine residues allows for the systematic investigation of glycosylation-dependent protein interactions and facilitates the development of glycopeptide-based probes for biochemical and structural studies.

Protein Engineering: In protein engineering, Fmoc-L-Thr(β-D-GlcNAc(Ac)3)-OH serves as a critical reagent for generating designer proteins with tailored glycosylation patterns. By incorporating this glycosylated amino acid into synthetic peptides or protein fragments, researchers can introduce precise O-GlcNAc modifications that are otherwise challenging to achieve through enzymatic methods. This approach is instrumental in dissecting the effects of glycosylation on protein function, dynamics, and interactions with other biomolecules. The use of such glycosylated building blocks has advanced the understanding of glycoprotein structure-function relationships and contributed to the development of novel protein-based materials and therapeutics.

Glycosylation Pathway Studies: The compound is also employed in studies aimed at elucidating the biosynthetic pathways and enzymatic mechanisms underlying protein O-GlcNAcylation. By synthesizing peptides containing β-D-GlcNAc-modified threonine residues, researchers can probe the substrate specificities of glycosyltransferases, O-GlcNAcases, and other enzymes involved in the dynamic regulation of protein glycosylation. These model substrates are essential for kinetic assays, inhibitor screening, and mechanistic studies that seek to unravel the complexities of cellular glycosylation pathways. The use of chemically defined glycopeptides enhances experimental reproducibility and provides new insights into the regulation of protein glycosylation in health and disease.

Antibody Development: Fmoc-L-Thr(β-D-GlcNAc(Ac)3)-OH is integral to the development of glycopeptide antigens for antibody generation and specificity testing. By synthesizing glycopeptides that display the β-D-GlcNAc modification at defined positions, researchers can create immunogens for raising antibodies that specifically recognize O-GlcNAc-modified proteins. These antibodies are powerful tools for detecting and quantifying protein glycosylation in various biological samples, enabling the study of glycosylation dynamics and its implications in cellular signaling, metabolism, and disease processes. The precise control over glycopeptide structure afforded by this compound ensures the generation of highly specific and sensitive immunoreagents.

Biomolecular Interaction Studies: The protected glycosylated threonine derivative is also valuable in the investigation of glycan-mediated biomolecular interactions. Synthetic glycopeptides incorporating this building block can be used in binding assays with lectins, carbohydrate-binding proteins, and other glycan-recognizing molecules to dissect the molecular determinants of glycan recognition. These studies provide critical insights into the roles of O-GlcNAc modifications in cell-cell communication, pathogen-host interactions, and immune recognition. By employing Fmoc-L-Thr(β-D-GlcNAc(Ac)3)-OH in the design of glycopeptide arrays and affinity probes, researchers can map glycan-binding specificities and advance the development of glycan-based diagnostics and therapeutics.

1. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

2. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

3. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

4. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

5. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die